Cargando…
Antitumor effects of brucine immuno-nanoparticles on hepatocellular carcinoma in vivo
In vitro and in vivo studies have demonstrated that brucine is able to inhibit the proliferation of liver cancer cells and growth of animal tumors, and may be a promising anticancer drug. However, high toxicity, poor water solubility, short half-life, narrow therapeutic window, and similar therapeut...
Autores principales: | Qin, Jianmin, Yang, Lin, Sheng, Xia, Sa, Zhongqiu, Huang, Tao, Li, Qi, Gao, Kepan, Chen, Qinghua, Ma, Jingwei, Shen, Hebai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920962/ https://www.ncbi.nlm.nih.gov/pubmed/29731843 http://dx.doi.org/10.3892/ol.2018.8168 |
Ejemplares similares
-
Anti-tumor effects of brucine immuno-nanoparticles on hepatocellular carcinoma
por: Qin, Jian-Min, et al.
Publicado: (2012) -
Stoichiometric and Nonstoichiometric Hydrates of Brucine
por: Braun, Doris E., et al.
Publicado: (2016) -
Development, optimization, and evaluation of PEGylated brucine-loaded PLGA
nanoparticles
por: Elsewedy, Heba S., et al.
Publicado: (2020) -
A Combination of In Silico ADMET Prediction, In Vivo Toxicity Evaluation, and Potential Mechanism Exploration of Brucine and Brucine N-oxide—A Comparative Study
por: Gao, Yan, et al.
Publicado: (2023) -
In vitro and in vivo evaluation of novel NGR-modified liposomes containing brucine
por: Li, Shu, et al.
Publicado: (2017)